Prometheus Biosciences Inc

Prometheus Biosciences Inc

RXDX

Market Cap$9.56B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Prometheus Biosciences IncPrometheus Biosciences Inc-57.3--21%--
$206.54

Current Fair Value

3.3% upside

Undervalued by 3.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.56 Billion
Enterprise Value$9.48 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.49
Beta-0.49
Outstanding Shares47,461,230

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-57.28
PEG-207.6
Price to Sales-
Price to Book Ratio14.28
Enterprise Value to Revenue2371.91
Enterprise Value to EBIT-58.19
Enterprise Value to Net Income-64
Total Debt to Enterprise0
Debt to Equity0.04

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Prometheus Biosciences Inc

26 employees

Prometheus Biosciences, Inc. is a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis...